{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:24:10Z","timestamp":1793157850103,"version":"4.5.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Hashimoto\u2019s thyroiditis (HT) and papillary thyroid carcinoma (PTC) co-occurrence raises significant questions regarding the immune microenvironment and molecular mechanisms in thyroid tumor development. This review synthesizes recent literature to explore the immune microenvironment and molecular characteristics of PTC patients with HT, and to analyze how these characteristics influence disease onset, progression, and treatment. We focused on the immunological and molecular biological mechanisms underlying the interaction between HT and PTC, particularly the recruitment and activation of immune cells and alterations in key signaling pathways. Studies indicate that PTC with HT exhibits distinctive immune microenvironmental features, such as the role of regulatory T cells (Tregs), activation of the IFN-\u03b3-mediated CXCR3A-CXCL10 signaling axis, and NF-\u03baB pathway activation. Additionally, thyroid-stimulating hormone (TSH) stimulation,\n                    <jats:italic>RET\/PTC<\/jats:italic>\n                    gene rearrangements, and changes in STAT6 and\n                    <jats:italic>DMBT1<\/jats:italic>\n                    gene expression levels also play significant roles in PTC development. Notably, while HT may increase the risk of PTC, patients with concurrent HT tend to have better prognoses. Future research should further elucidate the complex interplay between these two diseases to prevent the transformation of HT into PTC and offer more personalized treatment plans for PTC patients, including considerations for preoperative thyroidectomy and lymph node dissection strategies, as well as postoperative TSH suppression therapy risk assessment. This review underscores the importance of a deeper understanding of HT and PTC interactions and offers new perspectives for future research directions and therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2025.1551271","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:19:22Z","timestamp":1743380362000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by Hashimoto\u2019s thyroiditis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaohui","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kainan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.05.019","article-title":"Thyroid autoimmune disorders and cancer","volume":"64","author":"Ferrari","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1020709","article-title":"Global prevalence and epidemiological trends of hashimoto\u2019s thyroiditis in adults: A systematic review and meta-analysis","volume":"10","author":"Hu","year":"2022","journal-title":"Front Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.680873","article-title":"Significance of dmbt1 in papillary thyroid carcinoma concurrent with hashimoto\u2019s thyroiditis","volume":"11","author":"Gan","year":"2021","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-011-1130-x","article-title":"The incidence of lymphocytic thyroid infiltration and hashimoto\u2019s thyroiditis increased in patients operated for benign goiter over a 31-year period","volume":"459","author":"Ott","year":"2011","journal-title":"Virchows Archiv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10067-024-06888-6","article-title":"Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet","volume":"43","author":"Lichtiger","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential Malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the pd-1\/pd-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"Alvarez-Sierra","year":"2019","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04131","article-title":"Thyroid cancer trends in China and its comparative analysis with G20 countries: projections for 2020-2040","volume":"14","author":"Gong","year":"2024","journal-title":"J Glob Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-006-0001-5","article-title":"Radiation-induced thyroid cancer: what we have learned from chernobyl","volume":"17","author":"Nikiforov","year":"2006","journal-title":"Endocr Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to hashimoto disease of the thyroid gland","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0554","article-title":"Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the johns hopkins hospital surgical pathology records","volume":"23","author":"Caturegli","year":"2013","journal-title":"Thyroid\u00ae"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/eje-12-0903","article-title":"The association between papillary thyroid carcinoma and histologically proven hashimoto\u2019s thyroiditis: A meta-analysis","volume":"168","author":"Lee","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.23812\/j.biol.regul.homeost.agents.20233711.591","article-title":"The immunologic impact of hashimoto\u2019s thyroiditis on papillary thyroid carcinoma: A systematic research","volume":"37","author":"Xing","year":"2023","journal-title":"J Biol Regulators Homeostatic Agents"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to virchow","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","article-title":"Thyroid cancer and inflammation","volume":"321","author":"Guarino","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgu060","article-title":"Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing cxcl8","volume":"35","author":"Fang","year":"2014","journal-title":"Carcinogenesis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.959595","article-title":"Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience","volume":"12","author":"Cappellacci","year":"2022","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00580-w","article-title":"Thyroid carcinoma coexisting with hashimoto\u2019s thyreoiditis: clinicopathological and molecular characteristics clue up pathogenesis","volume":"25","author":"Moln\u00e1r","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801925","article-title":"Hashimoto\u2019s thyroiditis: A \u201cDouble-edged sword\u201d in thyroid carcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18526","article-title":"Prevalence of hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.3390\/cancers15082371","article-title":"Hashimoto\u2019s thyroiditis: A protective factor against recurrence in braf-wild type differentiated thyroid carcinoma","volume":"15","author":"Issa","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-011-9164-9","article-title":"Well-differentiated thyroid carcinoma with concomitant hashimoto\u2019s thyroiditis present with less aggressive clinical stage and low recurrence","volume":"22","author":"Huang","year":"2011","journal-title":"Endocrine Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad667","article-title":"Effect and interactions of braf on lymph node metastasis in papillary thyroid carcinoma with hashimoto thyroiditis","volume":"109","author":"Li","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-\u0393 and tumor necrosis factor-\u03b1 Sustain secretion of specific cxc chemokines in human thyrocytes: A first step toward a differentiation between autoimmune and tumor-related inflammation","volume":"98","author":"Rotondi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and th17\/treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-003-0444-1","article-title":"Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells","volume":"53","author":"Wei","year":"2004","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0569-y","article-title":"The possible role of cd4+Cd25highfoxp3+\/cd4+Il-17a+ Cell imbalance in the autoimmunity of patients with hashimoto thyroiditis","volume":"50","author":"Xue","year":"2015","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.959477","article-title":"The changes in peripheral blood th17 and treg ratios in hashimoto\u2019s thyroiditis are accompanied by differential pd-1\/pd-L1 expression","volume":"13","author":"Fang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1042511","article-title":"Leptin receptor antagonist attenuates experimental autoimmune thyroiditis in mice by regulating treg\/th17 cell differentiation","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1098243","article-title":"The role behind the scenes of tregs and th17s in hashimoto\u2019s thyroiditis: toward a pivotal role of foxp3 and bach2","volume":"13","author":"Mazzieri","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.01.003","article-title":"Immunological aspects of autoimmune thyroid disease \u2013 complex interplay between cells and cytokines","volume":"116","author":"Luty","year":"2019","journal-title":"Cytokine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211069012","article-title":"Tumor promoting roles of il-10, tgf-\u03b2, il-4, and il-35: its implications in cancer immunotherapy","volume":"10","author":"Mirlekar","year":"2022","journal-title":"SAGE Open Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and th17 lymphocytes in hashimoto\u2019s thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1347695","article-title":"Treg cells as a protective factor for hashimoto`S thyroiditis: A mendelian randomization study","volume":"15","author":"Guo","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1352616","article-title":"Causal role of immune cells in hashimoto\u2019s thyroiditis: mendelian randomization study","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (Ipex) syndrome: A systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02050","article-title":"Bach2 deficiency leads to spontaneous expansion of il-4-producing T follicular helper cells and autoimmunity","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.11.7433","article-title":"Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific cd4+Cd25+ T cells1","volume":"174","author":"Verginis","year":"2005","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of pd-L1: A novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaut.2011.01.002","article-title":"Analysis of the cumulative changes in graves\u2019 Disease thyroid glands points to ifn signature, plasmacytoid dcs and alternatively activated macrophages as chronicity determining factors","volume":"36","author":"Ruiz-Riol","year":"2011","journal-title":"J Autoimmun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1046\/j.1365-2249.1997.3811277.x","article-title":"Hyperexpression of transporter in antigen processing-1 (Tap-1) in thyroid glands affected by autoimmunity: A contributing factor to the breach of tolerance to thyroid antigens","volume":"109","author":"Sospedra","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90628-1","article-title":"Aberrant expression of hla-dr antigen on thyrocytes in graves\u2019 Disease: relevance for autoimmunity","volume":"2","author":"Hanafusa","year":"1983","journal-title":"Lancet (London England)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-8411(05)80056-3","article-title":"Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells","volume":"5","author":"Tolosa","year":"1992","journal-title":"J Autoimmun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/js.2018-00427","article-title":"The impact of hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer","volume":"3","author":"Silva de Morais","year":"2019","journal-title":"J Endocr Soc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.937871","article-title":"Cancer risk in hashimoto\u2019s thyroiditis: A systematic review and meta-analysis","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.35.2.443","article-title":"Mechanisms of the impact of hashimoto thyroiditis on papillary thyroid carcinoma progression: relationship with the tumor immune microenvironment","volume":"35","author":"Sulaieva","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.3390\/jcm12216817","article-title":"Tumor inflammatory microenvironment of the thyroid cancer: relationship between regulatory T-cell imbalance, and P-nf\u03bab (P65) expression-a preliminary study","volume":"12","author":"Pasquali","year":"2023","journal-title":"J Clin Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234566","article-title":"Genetic relationship between hashimoto`S thyroiditis and papillary thyroid carcinoma with coexisting hashimoto`S thyroiditis","volume":"15","author":"Subhi","year":"2020","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1140094","article-title":"Identifying and analyzing the key genes shared by papillary thyroid carcinoma and hashimoto\u2019s thyroiditis using bioinformatics methods","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0759-7","article-title":"T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity","volume":"52","author":"Gonz\u00e1lez-Amaro","year":"2016","journal-title":"Endocrine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.758339","article-title":"Papillary thyroid carcinoma landscape and its immunological link with hashimoto thyroiditis at single-cell resolution","volume":"9","author":"Pan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers14174287","article-title":"The immune landscape of papillary thyroid cancer in the context of autoimmune thyroiditis","volume":"14","author":"Pani","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (Time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1168556","article-title":"The immune network in thyroid cancer","volume":"5","author":"Galdiero","year":"2016","journal-title":"Oncoimmunology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12586","article-title":"Cd8+ Tumour-infiltrating lymphocytes and cox2 expression may predict relapse in differentiated thyroid cancer","volume":"83","author":"Cunha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00601","article-title":"Tissue infiltrating lti-like group 3 innate lymphoid cells and T follicular helper cells in graves\u2019 and hashimoto\u2019s thyroiditis","volume":"11","author":"Mohr","year":"2020","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0321-8","article-title":"Hmgcll1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia","volume":"33","author":"Park","year":"2019","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e03077","article-title":"Hashimoto\u2019s thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links","volume":"6","author":"Sulaieva","year":"2020","journal-title":"Heliyon"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of cxcr3 mediates the inhibition of endothelial cell growth induced by ip-10, mig, and I-tac, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.170324","article-title":"Cxcr3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1 *","volume":"285","author":"Datta","year":"2010","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4345","article-title":"Ras-induced modulation of cxcl10 and its receptor splice variant cxcr3-B in mda-mb-435 and mcf-7 cells: relevance for the development of human breast cancer","volume":"66","author":"Datta","year":"2006","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.05.034","article-title":"Differential expression patterns of cxcr3 variants and corresponding cxc chemokines in clear cell ovarian cancers and endometriosis","volume":"122","author":"Furuya","year":"2011","journal-title":"Gynecologic Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-11-3","article-title":"Altered cxcr3 isoform expression regulates prostate cancer cell migration and invasion","volume":"11","author":"Wu","year":"2012","journal-title":"Mol Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.08.267","article-title":"Interferon-\u03b1, -\u03b2 and -\u03b3 Induce cxcl11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor \u0393 Agonists","volume":"218","author":"Antonelli","year":"2013","journal-title":"Immunobiology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce cxcl9 and cxcl10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23502","article-title":"Differential expression profile of cxcr3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis","volume":"9","author":"Urra","year":"2018","journal-title":"Oncotarget"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00378.2019","article-title":"The cc and cxc chemokines: major regulators of tumor progression and the tumor microenvironment","volume":"318","author":"Bikfalvi","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2217\/imt.11.115","article-title":"Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors","volume":"3","author":"Lechner","year":"2011","journal-title":"Immunotherapy"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7150\/jca.38330","article-title":"Il-2 enhanced mhc class I expression in papillary thyroid cancer with hashimoto\u2019s thyroiditis overcomes immune escape in vitro","volume":"11","author":"Hu","year":"2020","journal-title":"J Cancer"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1652-6","article-title":"The prognostic significance of stable disease following high-dose interleukin-2 (Il-2) treatment in patients with metastatic melanoma and renal cell carcinoma","volume":"64","author":"Hughes","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose il-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106296","article-title":"Interleukin-2 as immunotherapeutic in the autoimmune diseases","volume":"81","author":"Orozco Valencia","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2380-z","article-title":"Curcumin induces G2\/M arrest, apoptosis, nf-\u03bab inhibition, and expression of differentiation genes in thyroid carcinoma cells","volume":"143","author":"Schwertheim","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00054","article-title":"Ret\/ptc translocations and clinico-pathological features in human papillary thyroid carcinoma","volume":"3","author":"Romei","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0240","article-title":"Ret\/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of hashimoto\u2019s thyroiditis share low-level recombination events with a subset of papillary carcinoma","volume":"91","author":"Rhoden","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","article-title":"Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children","volume":"57","author":"Nikiforov","year":"1997","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00284","article-title":"Sonic hedgehog signaling in thyroid cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.7.4059","article-title":"Proinflammatory mediators and genetic background in oncogene mediated tumor progression","volume":"172","author":"Russell","year":"2004","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206112","article-title":"Ras-mediated apoptosis of pc cl 3 rat thyroid cells induced by ret\/ptc oncogenes","volume":"22","author":"Castellone","year":"2003","journal-title":"Oncogene"},{"key":"B83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/106689690201000104","article-title":"Prevalence of ret\/ptc rearrangements in hashimoto\u2019s thyroiditis and papillary thyroid carcinomas","volume":"10","author":"Nikiforova","year":"2002","journal-title":"Int J Surg Pathol"},{"key":"B84","article-title":"The ret\/ptc3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids1","volume":"58","author":"Powell","year":"1998","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02020","article-title":"High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies","volume":"153","author":"Boi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1159\/000468928","article-title":"Thyroid autoimmunity and thyroid cancer: review focused on cytological studies","volume":"6","author":"Boi","year":"2017","journal-title":"Eur Thyroid J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mce.2003.10.029","article-title":"Tsh-activated signaling pathways in thyroid tumorigenesis","volume":"213","author":"Rivas","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B90","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjsurg.2009.08.028","article-title":"The utility of preoperative serum thyroid-stimulating hormone level for predicting Malignant nodular thyroid disease","volume":"199","author":"Jin","year":"2010","journal-title":"Am J Surg"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1083","article-title":"Thyrotropin and thyroid cancer diagnosis: A systematic review and dose-response meta-analysis","volume":"97","author":"McLeod","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2006.01.004","article-title":"Signaling mechanisms, interaction partners, and target genes of stat6","volume":"17","author":"Hebenstreit","year":"2006","journal-title":"Cytokine Growth factor Rev"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.59.070190.001321","article-title":"Cadherins: A molecular family important in selective cell-cell adhesion","volume":"59","author":"Takeichi","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14101","article-title":"N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways","volume":"8","author":"Da","year":"2017","journal-title":"Oncotarget"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00857-6","article-title":"Papillary Thyroid Cancer with Hashimoto\u2019s Thyroiditis Attenuates the Tumour Aggressiveness through the up-Regulation of E-Cadherin and Tgf-\u03b2 Expression","volume":"23","author":"Kim","year":"2023","journal-title":"Clin Exp Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-014-0022-x","article-title":"Differential expression of transforming growth factor-beta in benign vs. Papillary thyroid cancer nodules; a potential diagnostic tool","volume":"43","author":"Brace","year":"2014","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-2029-0","article-title":"Intercellular adhesion molecule-1 (Icam-1) is upregulated in aggressive papillary thyroid carcinoma","volume":"19","author":"Buitrago","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B99","article-title":"Dmbt1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer","volume":"60","author":"Mollenhauer","year":"2000","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-4-46","article-title":"Dmbt1 expression is down-regulated in breast cancer","volume":"4","author":"Braidotti","year":"2004","journal-title":"BMC Cancer"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04082.x","article-title":"Expression of deleted in Malignant brain tumours 1 (Dmbt1) relates to the proliferation and Malignant transformation of hepatic progenitor cells in hepatitis B virus-related liver diseases","volume":"60","author":"Deng","year":"2012","journal-title":"Histopathology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000000267","article-title":"High suppressor of cytokine signaling-3 expression impairs stat3-dependent protective effects of interleukin-22 in ulcerative colitis in remission","volume":"21","author":"Xu","year":"2014","journal-title":"Inflammatory Bowel Dis"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10639","article-title":"Expression of pdk\u22121 and dmbt1 in the thyroid carcinoma and its clinicopathological significance","volume":"18","author":"Sun","year":"2019","journal-title":"Oncol Lett"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ15-0234","article-title":"Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with hashimoto thyroiditis","volume":"62","author":"Yi","year":"2015","journal-title":"Endocrine J"},{"key":"B105","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2009.10.010","article-title":"Role of nf-kappab in thyroid cancer","volume":"321","author":"Pacifico","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.7150\/jca.95501","article-title":"Tle4 downregulation identified by wgcna and machine learning algorithm promotes papillary thyroid carcinoma progression via activating jak\/stat pathway","volume":"15","author":"Lin","year":"2024","journal-title":"J Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3390\/cancers15030710","article-title":"Mapk pathway inhibitors in thyroid cancer: preclinical and clinical data","volume":"15","author":"Schubert","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"11989","DOI":"10.3390\/ijms231911989","article-title":"Interaction of mrpl9 and ggct promotes cell proliferation and migration by activating the mapk\/erk pathway in papillary thyroid cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40291-015-0175-y","article-title":"Pi3k\/akt pathway and its mediators in thyroid carcinomas","volume":"20","author":"Nozhat","year":"2016","journal-title":"Mol Diagn Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:19:35Z","timestamp":1743380375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1551271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":109,"alternative-id":["10.3389\/fendo.2025.1551271"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1551271","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"1551271"}}